Antonio Lanzavecchia

Antonio Lanzavecchia's AcademicInfluence.com Rankings

Biology

#1209

World Rank

#2056

Historical Rank

Immunology

#45

World Rank

#49

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Antonio Lanzavecchia Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Antonio Lanzavecchia is an Italian and Swiss immunologist. As a fellow of Collegio Borromeo he obtained a degree with honors in Medicine in 1976 from the University of Pavia where he specialized in Pediatrics and Infectious Diseases. He is Head Human Immunology Program, Istituto Nazionale di Genetica Molecolare-INGM, Milan and SVP Senior research Fellow, Humabs/Vir Biotechnology, Bellinzona and San Francisco . Since 2017, he is also Professor at the Faculty of Biomedical Sciences of the Università della Svizzera italiana .

(See a Problem?)

Antonio Lanzavecchia's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha (1994) (5652)
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions (1999) (4984)
Central memory and effector memory T cell subsets: function, generation, and maintenance. (2004) (2991)
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products (1995) (2769)
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation (1996) (2369)
Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon (1999) (1890)
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells (2007) (1867)
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes (1998) (1748)
Origin, maturation and antigen presenting function of dendritic cells. (1997) (1476)
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody (2020) (1411)
Antigen-specific interaction between T and B cells (1985) (1396)
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells (2002) (1364)
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation (1998) (1332)
Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells (2000) (1303)
Serial triggering of many T-cell receptors by a few peptideMHC complexes (1995) (1288)
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells (1997) (1260)
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions (1999) (1224)
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells (2005) (1219)
The role of chemokine receptors in primary, effector, and memory immune responses. (2000) (1178)
T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds (1996) (1172)
Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. (1997) (1165)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells (2007) (1147)
C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE (2009) (1099)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins (2011) (1086)
T lymphocyte costimulation mediated by reorganization of membrane microdomains. (1999) (1080)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells (2009) (1059)
Regulation of T Cell Immunity by Dendritic Cells (2001) (1058)
The duration of antigenic stimulation determines the fate of naive and effector T cells. (1998) (1016)
Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. (2007) (1001)
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. (1998) (998)
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice (2004) (995)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology (2020) (957)
Regulation of Dendritic Cell Migration to the Draining Lymph Node (2003) (927)
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization (2000) (905)
Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells (2001) (895)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming (2004) (877)
Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. (2000) (866)
L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity (2016) (855)
BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction (2001) (843)
Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA (1999) (838)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β (2012) (791)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2015) (767)
Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. (2004) (767)
Distinct patterns and kinetics of chemokine production regulate dendritic cell function (1999) (761)
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells (1989) (715)
A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. (2003) (710)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus (2004) (698)
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) (670)
The Dendritic Cell-Specific Adhesion Receptor DC-SIGN Internalizes Antigen for Presentation to T Cells1 (2002) (660)
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection (2016) (646)
Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. (1990) (643)
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. (2003) (613)
Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton (1995) (596)
Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression (2000) (579)
Expression of two T cell receptor alpha chains: dual receptor T cells. (1993) (565)
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2021) (562)
T cell fitness determined by signal strength (2003) (562)
Opinion-decision making in the immune system: Progressive differentiation and selection of the fittest in the immune response (2002) (559)
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion (2019) (548)
From vaccines to memory and back. (2010) (546)
Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation (1999) (532)
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. (2010) (530)
Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy (1996) (513)
Understanding the generation and function of memory T cell subsets. (2005) (494)
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. (1997) (488)
Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T Cells (2001) (480)
Toll‐like receptor stimulation as a third signal required for activation of human naive B cells (2006) (459)
Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals (2010) (458)
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells (1994) (456)
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. (2010) (453)
A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing (1997) (438)
Broadly neutralizing antiviral antibodies. (2013) (435)
The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. (2001) (429)
From TCR Engagement to T Cell Activation A Kinetic View of T Cell Behavior (1999) (425)
The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells (1997) (422)
Inhibition of dendritic cell maturation by herpes simplex virus (1999) (420)
Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. (2013) (416)
Cytokine-driven proliferation and differentiation of human naïve, central memory and effector memory CD4+ T cells. (2001) (411)
Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells (1999) (404)
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia (2005) (399)
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease (2016) (396)
Memory and flexibility of cytokine gene expression as separable properties of human TH1 and TH2 lymphocytes (2003) (392)
Mechanisms of antigen uptake for presentation. (1996) (379)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2 (2020) (378)
Immunology: Licence to kill (1998) (377)
Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. (2012) (375)
Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. (1995) (363)
T cell costimulation by chemokine receptors (2005) (359)
SARS-like WIV1-CoV poised for human emergence (2016) (350)
Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity (2009) (350)
Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes (1992) (349)
Degradation of T Cell Receptor (TCR)–CD3-ζ Complexes after Antigenic Stimulation (1997) (344)
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody (2016) (329)
Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming (2000) (325)
Chemokine Receptor Expression Identifies Pre–T Helper (Th)1, Pre–Th2, and Nonpolarized Cells among Human CD4+ Central Memory T Cells (2004) (315)
Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex (2009) (309)
Selective Inhibition of Ii-dependent Antigen Presentation by Helicobacter pylori Toxin VacA (1998) (298)
Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants (1995) (297)
Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells (1991) (289)
Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines (2015) (285)
Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation (1993) (285)
Antigen decoding by T lymphocytes: from synapses to fate determination (2001) (285)
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies (2007) (281)
T cells can present antigens such as HIV gp120 targeted to their own surface molecules (1988) (280)
Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes (2016) (275)
How can cryptic epitopes trigger autoimmunity? (1995) (274)
Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. (1997) (262)
High-avidity IgA protects the intestine by enchaining growing bacteria (2017) (261)
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors (2015) (260)
Rapid development of broadly influenza neutralizing antibodies through redundant mutations (2014) (253)
The instructive role of dendritic cells on T-cell responses (2002) (253)
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus (2019) (250)
Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation (2012) (249)
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. (2005) (247)
Social network architecture of human immune cells unveiled by quantitative proteomics (2017) (244)
Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza (2007) (221)
The interplay between the duration of TCR and cytokine signaling determines T cell polarization (1999) (221)
L-selectin-negative CCR7− effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells (2007) (219)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody (2013) (217)
T cells in patients with narcolepsy target self-antigens of hypocretin neurons (2018) (213)
Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells (2009) (211)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus (2015) (209)
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection (2011) (207)
Duration, combination and timing: the signal integration model of dendritic cell activation. (2007) (206)
Identifying strategies for immune intervention. (1993) (206)
Pivotal Role of Dendritic Cell–derived CXCL10 in the Retention of T Helper Cell 1 Lymphocytes in Secondary Lymph Nodes (2002) (202)
Migration and Function of Antigen-Primed Nonpolarized T Lymphocytes in Vivo (2001) (202)
The use of hybrid hybridomas to target human cytotoxic T lymphocytes (1987) (202)
Dendritic cells up‐regulate immunoproteasomes and the proteasome regulator PA28 during maturation (1999) (198)
ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells (2005) (191)
Clonal dissection of the human memory B‐cell repertoire following infection and vaccination (2009) (191)
Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells (1991) (191)
Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. (1985) (188)
Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes (1991) (184)
Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon–producing and dendritic cell development (2006) (180)
Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets (2009) (179)
Suppressive effect of antibody on processing of T cell epitopes (1993) (177)
Understanding and making use of human memory B cells (2006) (175)
Organization of plasma membrane functional rafts upon T cell activation (2001) (175)
Irreversible association of peptides with class II MHC molecules in living cells (1992) (175)
Broad betacoronavirus neutralization by a stem helix–specific human antibody (2021) (173)
Fetal Human Cytomegalovirus Transmission Correlates with Delayed Maternal Antibodies to gH/gL/pUL128-130-131 Complex during Primary Infection (2013) (170)
Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells (1999) (169)
From synapses to immunological memory: the role of sustained T cell stimulation. (2000) (169)
Structural and molecular basis for Ebola virus neutralization by protective human antibodies (2016) (166)
Toll-like receptors and innate immunity in B-cell activation and antibody responses. (2007) (165)
T‐cell trafficking in the central nervous system (2012) (160)
Functional subsets of memory T cells identified by CCR7 expression. (2000) (159)
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies (2021) (159)
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. (2013) (158)
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift (2021) (157)
Molecular analysis of human gamma/delta+ clones from thymus and peripheral blood (1989) (156)
Human Th17 subsets (2012) (155)
Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin- derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition (1992) (154)
Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge (2008) (152)
An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor (2018) (152)
A public antibody lineage that potently inhibits malaria infection by dual binding to the circumsporozoite protein (2018) (150)
Antigen Uptake and Accumulation in Antigen‐Specific B Cells (1987) (147)
Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion (1995) (146)
Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer (2016) (146)
Antigen dependent and independent mechanisms that sustain serum antibody levels. (2003) (143)
Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. (2012) (140)
Delineation of several DR-restricted tetanus toxin T cell epitopes. (1989) (139)
In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset (1993) (139)
T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification (2002) (137)
Mannose receptor mediated antigen uptake and presentation in human dendritic cells. (1997) (134)
Exploring pathways for memory T cell generation. (2001) (132)
Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells (2003) (131)
Prostaglandin E2 enhances Th17 responses via modulation of IL‐17 and IFN‐γ production by memory CD4+ T cells (2009) (131)
The Role of Aquaporins in Dendritic Cell Macropinocytosis (2000) (130)
A LAIR-1 insertion generates broadly reactive antibodies against malaria variant antigens (2015) (126)
Tackling influenza with broadly neutralizing antibodies (2017) (118)
Professional presentation of antigen by activated human T cells (1994) (118)
Ontogeny of Secretory Immunity: Levels of Secretory IgA and Natural Antibodies in Saliva (1980) (117)
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies (2014) (117)
Dissecting the human immunologic memory for pathogens (2011) (115)
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential (2017) (114)
Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets (1988) (114)
Structural and functional analysis of a potent sarbecovirus neutralizing antibody (2020) (112)
From TCR Engagement to Minireview T Cell Activation: A Kinetic View of T Cell Behavior (1999) (111)
kappa+lambda+ dual receptor B cells are present in the human peripheral repertoire (1995) (108)
Division of Labor with a Workforce of One: Challenges in Specifying Effector and Memory T Cell Fate (2007) (108)
Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study. (1992) (108)
Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. (1997) (107)
Dendritic cell migration to peripheral lymph nodes. (2009) (107)
Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA (2007) (107)
The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86 (1993) (107)
Quantitative Contribution of CD4 and CD8 to T Cell Antigen Receptor Serial Triggering (1997) (104)
Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells (2000) (103)
Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. (1993) (103)
A functional BCR in human IgA and IgM plasma cells. (2013) (102)
Human B cell memory (2009) (98)
Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. (1988) (97)
A role for Toll-like receptors in acquired immunity : up-regulation of TLR 9 by BCR triggering in naive B cells and constitutive expression in memory B cells (2003) (96)
Dendritic cell-derived IL-2 production is regulated by IL-15 in humans and in mice. (2005) (95)
A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding. (2002) (94)
Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus (2010) (94)
Human Th17 cells in infection and autoimmunity. (2009) (92)
Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo (2012) (90)
A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expression (2006) (87)
Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles (2019) (87)
An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV (2011) (86)
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases (2006) (86)
The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells (2013) (84)
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells (2016) (84)
Public antibodies to malaria antigens generated by two LAIR1 insertion modalities (2017) (83)
Dynamics in protein translation sustaining T cell preparedness (2020) (81)
Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components (1988) (80)
Signal extinction and T cell repolarization in T helper cell‐antigen‐presenting cell conjugates (1996) (79)
Agonist‐induced T cell receptor down‐regulation: molecular requirements and dissociation from T cell activation (1997) (79)
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cells. (1991) (78)
Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41 (2010) (78)
Immune subversion by Helicobacter pylori. (2005) (78)
Influenza hemagglutinin membrane anchor (2018) (76)
CD40L+ CD4+ memory T cells migrate in a CD62P-dependent fashion into reactive lymph nodes and license dendritic cells for T cell priming (2008) (76)
Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations. (2019) (74)
Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 (2021) (74)
Recognition by class II alloreactive T cells of processed determinants from human serum proteins (1991) (73)
An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells (2018) (73)
Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis (2015) (73)
Human anti–HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness (2010) (72)
Mouse pre‐immunocytes as non‐proliferating multipotent precursors of macrophages, interferon‐producing cells, CD8α+ and CD8α– dendritic cells (2001) (72)
CD40 ligand‐independent B cell activation revealed by CD40 ligand‐deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation (1995) (71)
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies (2021) (70)
Understanding the Mechanisms of Sustained Signaling and T Cell Activation (1997) (69)
Human monoclonal antibodies by immortalization of memory B cells (2007) (69)
Role of cAMP in regulating cytotoxic T lymphocyte adhesion and motility (1993) (69)
The challenges of primary biliary cholangitis: What is new and what needs to be done. (2019) (68)
Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies (2013) (65)
Activation of src‐family tyrosine kinases by LPS regulates cytokine production in dendritic cells by controlling AP‐1 formation (2003) (65)
One out of five peripheral blood B lymphocytes is activated to high‐rate Ig production by human alloreactive T cell clones (1983) (64)
Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4+ T cells in allogeneic bone marrow transplantation recipients. (1996) (63)
CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infection. (2008) (63)
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis (2016) (61)
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients. (2021) (61)
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge. (2015) (60)
Chondroitin Sulfate A-Adhering Plasmodium falciparum-Infected Erythrocytes Express Functionally Important Antibody Epitopes Shared by Multiple Variants (2010) (60)
Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland (2020) (58)
Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation (2016) (58)
Within-Host Evolution Results in Antigenically Distinct GII.4 Noroviruses (2014) (58)
Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen (1992) (56)
Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways. (1989) (56)
Is the T-cell receptor involved in T-cell killing? (1986) (56)
CCR6 is expressed on an IL-10–producing, autoreactive memory T cell population with context-dependent regulatory function (2010) (56)
Activation of human B lymphocytes: frequency of antigen‐specific B cells triggered by alloreactive or by antigen‐specific T cell clones (1983) (55)
Kinetics of MHC-antigen complex formation on antigen-presenting cells. (1988) (54)
Clonal expansions of Vδ1+ and Vδ2+ cells increase with age and limit the repertoire of human γδ T cells (1994) (53)
An Invariant vo 124-Jc ~ Q / V 311 T Cell Receptor Is Expressed in All Individuals by Clonally Expanded CD 4-8-T Cells (2003) (53)
Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein (2009) (53)
Re‐expression of RAG‐1 and RAG‐2 genes and evidence for secondary rearrangements in human germinal center B lymphocytes (1998) (52)
Particle Conformation Regulates Antibody Access to a Conserved GII.4 Norovirus Blockade Epitope (2014) (51)
Improved Innate and Adaptive Immunostimulation by Genetically Modified HIV-1 Protein Expressing NYVAC Vectors (2011) (51)
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4 (2018) (51)
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages (2022) (50)
Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children. (1978) (50)
Dual Receptor T‐Cells (1995) (49)
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae (2017) (48)
Cutting Edge: Recombinase-Activating Gene Expression and V(D)J Recombination in CD4+CD3low Mature T Lymphocytes1 (2000) (47)
Antibody-guided vaccine design: identification of protective epitopes. (2016) (47)
Optimizing anti‐CD3 affinity for effective T cell targeting against tumor cells (2002) (47)
Activation of mononuclear cells to be used for hybrid monoclonal antibody‐induced lysis of human ovarian carcinoma cells (1988) (45)
The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells. (1999) (45)
In vitro selective expansion of allergen specific T cells from atopic patients. (1983) (45)
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody (2015) (44)
In vitro stimulation of IgE production at a single precursor level by human alloreactive T helper clones. (1984) (44)
Functional analysis of two tetanus toxin universal T cell epitopes in their interaction with DR1101 and DR1104 alleles. (1994) (43)
Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell (1989) (43)
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01 (2019) (42)
Selection by Two Powerful Antigens May Account for the Presence of the Major Population of Human Peripheral-y / 6 T Cells (2003) (42)
In Vivo Persistence of Expanded Clones Specific for Bacterial Antigens within the Human T Cell Receptor ce//~ CD4-8- Subset By Paolo Dellabona,* Giulia Casorati,* Brigitte Friedli, (1993) (42)
Specific B lymphocytes efficiently pick up, process and present antigen to T cells. (1985) (41)
Regulation of peripheral T cell activation by calreticulin (2006) (41)
Dendritic cell maturation and generation of immune responses. (1999) (40)
TCR-independent proliferation and differentiation of human CD4+ T cell subsets induced by cytokines. (2002) (40)
The strength of T cell stimulation determines IL‐7 responsiveness, secondary expansion, and lineage commitment of primed human CD4+IL‐7Rhi T cells (2008) (40)
New perspectives on immunointervention in autoimmune diseases. (1990) (40)
Macrophage Death following Influenza Vaccination Initiates the Inflammatory Response that Promotes Dendritic Cell Function in the Draining Lymph Node. (2017) (39)
Characterization of severe acute respiratory syndrome coronavirus membrane protein (2006) (39)
Variable domain N‐linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B‐cell selection (2018) (38)
Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumors. (2003) (38)
Rational Engineering of a Human Anti-Dengue Antibody through Experimentally Validated Computational Docking (2013) (38)
A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients (2019) (38)
Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion (2018) (38)
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus (2017) (38)
Do Memory CD4 T Cells Keep Their Cell-Type Programming: Plasticity versus Fate Commitment? T-Cell Heterogeneity, Plasticity, and Selection in Humans. (2018) (38)
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2021) (37)
SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies (2021) (36)
Human Adaptive Immune System Rag2−/−γc−/− Mice (2005) (36)
Protection of calves by a prefusion-stabilized bovine RSV F vaccine (2017) (35)
Efficient Methods To Isolate Human Monoclonal Antibodies from Memory B Cells and Plasma Cells. (2014) (35)
Lead and follow: the dance of the dendritic cell and T cell (2004) (35)
ERK phosphorylation and miR-181a expression modulate activation of human memory TH17 cells (2015) (35)
Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. (1995) (35)
Antigen presentation by B lymphocytes: a critical step in T-B collaboration. (1986) (33)
Lack of fair play in the T cell response (2002) (33)
Distinct expression pattern of IFN-α and TNF-α in juvenile idiopathic arthritis synovial tissue (2006) (33)
Is suppression a function of class II--restricted cytotoxic T cells? (1989) (33)
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome (2016) (33)
Somatic mutations and affinity maturation are impaired by excessive numbers of T follicular helper cells and restored by Treg cells or memory T cells (2015) (32)
Strain-Transcending Fc-Dependent Killing of Plasmodium falciparum by Merozoite Surface Protein 2 Allele-Specific Human Antibodies (2010) (32)
Pillars article: two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999. 401: 708-712. (2014) (31)
Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies (2013) (30)
Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions. (1991) (30)
T cell clones with normal or defective O‐galactosylation from a patient with permanent mixed‐field polyagglutinability (1992) (29)
Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses (2015) (29)
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody (2020) (29)
Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells. (2001) (28)
Role of B cells in TH cell responses in a mouse model of asthma (2017) (28)
In vivo localization of a bispecific antibody which targets human t lymphocytes to lyse human colon cancer cells (1989) (28)
T cell epitope analysis with peptides simultaneously synthesized on cellulose membranes: Fine mapping of two DQ dependent epitopes (1994) (28)
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies (2022) (28)
A novel and simple procedure for determining T cell epitopes in protein antigens. (1989) (27)
Infections and Organ Transplantation: New Challenges for Prevention and Treatment—A Colloquium (2012) (26)
In vitro synthesis of human IgE: reappraisal of a 5-year study. (1985) (26)
Molecularly specific detection of bacterial lipoteichoic acid for diagnosis of prosthetic joint infection of the bone (2018) (25)
Mouse pre-immunocytes as non-proliferating multipotent precursors of macrophages, interferon-producing cells, CD8alpha(+) and CD8alpha(-) dendritic cells. (2001) (25)
A T cell receptor (TCR) antagonist competitively inhibits serial TCR triggering by low‐affinity ligands, but does not affect triggering by high‐affinity anti‐CD3 antibodies (1997) (25)
Clonally expanded EOMES+ Tr1-like cells in primary and metastatic tumors are associated with disease progression (2021) (25)
Monocytes Join the Dendritic Cell Family (2010) (24)
Clonal sketches of the immune response. (1988) (24)
Human adaptive immune system Rag2-/-gamma(c)-/- mice. (2005) (23)
Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H 5 N 1 Influenza (2007) (23)
Janusin: new molecular design for bispecific reagents. (1992) (23)
Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C (2012) (22)
Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis (2016) (22)
Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies (2021) (22)
Memory in disguise (2011) (21)
Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin (2020) (20)
Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission (2017) (20)
Regulation of PfEMP1–VAR2CSA translation by a Plasmodium translation-enhancing factor (2017) (20)
Study on the immunogenicity of human class-II-restricted T-cell epitopes: processing constraints, degenerate binding, and promiscuous recognition. (1989) (20)
Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-c production by memory (2009) (20)
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages (2022) (19)
Cdk9/Cyclin T1 complex: A key player during the activation/differentiation process of normal lymphoid B cells (2008) (19)
In Vivo Persistence of Expanded Clones Specific for Bacterial Antigens within the Human T Cell Receptor ce / / ~ CD 4-8-Subset By (2003) (19)
Baculovirus cDNA libraries for expression cloning of genes encoding cell-surface antigens. (1997) (18)
Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue. (2007) (18)
Human monoclonal IgG selection of Plasmodium falciparum for the expression of placental malaria-specific variant surface antigens (2009) (18)
T cell activation by a bispecific anti‐CD3/anti‐major histocompatibility complex class I antibody (1990) (18)
High throughput cellular screens to interrogate the human T and B cell repertoires. (2011) (18)
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature (2021) (17)
Polyclonal Activation of Human B Lymphocytes in Vitro by Pokeweed Mitogen: a Simple Technique for the Simultaneous Assessment of Cell Proliferation, Generation of Plasma Cells, Plaque‐forming Cells and Immunoglobulin Production (1978) (17)
Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity (2021) (17)
Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients (2022) (17)
The Antibody Response to Plasmodium falciparum: Cues for Vaccine Design and the Discovery of Receptor-Based Antibodies. (2019) (17)
Clonal expansions of V delta 1+ and V delta 2+ cells increase with age and limit the repertoire of human gamma delta T cells. (1994) (17)
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery (2021) (16)
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion (2020) (16)
Plaque Assay with Protein A‐coated Erythrocytes for the Evaluation of Human Immunoglobulin‐secreting Cells Induced by Pokeweed Mitogen (1979) (16)
Molecular Signatures of Immunity and Immunogenicity in Infection and Vaccination (2017) (15)
From antigen presentation to T-cell activation. (1998) (15)
Peptide partners call the tune (1994) (14)
Characterization of Neutralizing Profiles in HIV-1 Infected Patients from whom the HJ16, HGN194 and HK20 mAbs were Obtained (2011) (13)
Lysis of nonnucleated red blood cells by cytotoxic T lymphocytes (1987) (13)
CD4+CD25+ Treg regulate the contribution of CD8+ T‐cell subsets in repopulation of the lymphopenic environment (2010) (13)
Establishment of human double-positive thymocyte clones (1989) (12)
IMMUNODEFICIENCY IN DOWN'S SYNDROME (1978) (12)
Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C (2012) (12)
Correction: Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2016) (12)
Dissecting human antibody responses: useful, basic and surprising findings (2018) (11)
Chemoattractant receptors and immune responses (1999) (11)
Contents, Vol. 76, Supplement 1, 1985 (1985) (11)
Memory T Cell Subsets (2003) (11)
A rationally designed oral vaccine induces Immunoglobulin A in the murine gut that directs the evolution of attenuated Salmonella variants (2019) (11)
Pillars article: Antigen-specific interaction between T and B cells. 1985. (2007) (11)
Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation. (2020) (10)
AncesTree: An interactive immunoglobulin lineage tree visualizer (2020) (10)
Crystal Structure and Size-Dependent Neutralization Properties of HK 20 , a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp 41 (2010) (10)
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire (2020) (9)
Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2020) (9)
Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts (2022) (9)
All known cross-reactive HIV-1 neutralizing antibodies are highly divergent from germline and their elicitation may require prolonged periods of time (2008) (9)
Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses (2021) (8)
Exploiting the immune system's own strategies for immunotherapy. (1988) (8)
Three signals and a master switch in the regulation of T-cell immunity. (1999) (8)
Erratum: Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer (2016) (8)
Ralph M. Steinman 1943–2011 (2011) (8)
Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein (2021) (8)
SARS-like cluster of circulating bat coronavirus pose threat for human emergence (2016) (7)
The same human alloreactive T cell clone can help both B lymphocytes and specific cytotoxic precursors (1984) (7)
Presentation to T Cells Receptor DC-SIGN Internalizes Antigen for The Dendritic Cell-Specific Adhesion (2002) (7)
Harming and protecting responses to HIV. (1989) (7)
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants (2023) (6)
16 – Isolation of Human Alloreactive T Helper Clones and Their Use as Polyclonal Activators of B Cells (1985) (6)
Correction: The Neonatal Fc Receptor (FcRn) Enhances Human Immunodeficiency Virus Type 1 (HIV-1) Transcytosis across Epithelial Cells (2013) (5)
Peptide binding and editing: generation of TCR ligands. (1998) (5)
Identification of a Novel Non-desmoglein Autoantigen in Pemphigus Vulgaris (2019) (5)
18 – On the Role of B Cell Surface Ig in Antigen Presentation to T Cells (1988) (5)
Pillars Article: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 1994. 179:1109-1118. (2018) (5)
Structural basis of malaria RIFIN binding by LILRB1-containing antibodies (2021) (5)
Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection (2011) (5)
Chemical and functional analysis of MHC class II-restricted T cell epitopes. (1991) (4)
BDCA-2, a Novel Plasmacytoid Dendritic Cell–speciﬁc Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon (cid:2) / (cid:3) Induction (2001) (4)
ACE2 engagement exposes the fusion peptide to pan-coronavirus neutralizing antibodies (2022) (4)
Exceptionally potent human monoclonal antibodies are effective for prophylaxis and therapy of tetanus in mice. (2021) (3)
Erratum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (Nature Medicine(2015) DOI: 10.1038/nm.3985) (2016) (3)
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients (2021) (3)
Activation of Human Peripheral Blood Lymphocytes: Effect of Concanavalin A and Lipopolysaccharide on in Vitro Synthesis of DNA and Immunoglobulins (1980) (3)
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies (2022) (3)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (2015) (3)
Correlation Between TCRV Gene Usage and Antigen Specificities in Human γδ T Cells (1991) (3)
Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody (2019) (2)
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges (2021) (2)
Correlation between TCR V gene usage and antigen specificities in human gamma delta T cells. (1991) (2)
Mature T LymphocyteslowCD 3 + CD 4 Expression and V ( D ) J Recombination in Cutting Edge : Recombinase-Activating Gene (2000) (2)
Characterization of τ δ TCR in T Cell Clones from Small Intestine of Coeliac Disease Patients (1991) (2)
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape (2022) (2)
Concanavalin A induces a T-cell dependent activation of human tonsil B cells in vitro. (1980) (2)
subsets in response to antigen or homeostatic cytokines memory T-cell + Proliferation and differentiation potential of human CD8 (2013) (2)
Activated Lymph Nodes Recruit Blood Borne NK Cells and Effector T Cells:Implications for Adaptive T Cell Responses (2008) (2)
Human T lymphocyte subset identification according to avidity for sheep erythrocytes and rosetting capacity with allogeneic red blood cells. (1977) (2)
Hierarchy of Human B Cell Regeneration after Rituximab Therapy. (2006) (2)
Publisher Correction: An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells (2018) (2)
Peptide Binding to MHC Class II Molecules in Living Cells: Role of Class II Synthesis and Stability of Peptide/Class II Complexes (1993) (1)
Clonal dissection of immunodominance and cross-reactivity of the CD4+ T cell response to SARS-CoV-2 (2021) (1)
Vaccination and immunological memory (2003) (1)
Common variable immunodeficiency: long term clinical consequencies of splenectomy in a case of late-onset hypogammaglobulinaemia. (1978) (1)
Mapping of T Cell Epitopes in Proteins: A Chemical Approach (1990) (1)
Prevention of Viral Spread, Viremia Reduction and HBsAg Clearance in Hepatitis B and D Coinfected Humanized Mice by a Human Neutralizing Monoclonal Antibody (2016) (1)
Advances in understanding of mechanisms of IgE disregulation in atopy by the application of in vitro methods. (1986) (1)
of peripheral T cell activation by calreticulin (2006) (1)
Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein (2021) (1)
A dramatic representation of immunological cooperative events. (1985) (1)
Current Opinion in Immunology. Vaccines. Introduction. (2010) (1)
Memory stem cells (2002) (1)
A perspective on potential antibody-dependent enhancement of SARS-CoV-2 (2020) (1)
Effect of in vitro treatment with reducing drugs on structure and function of human secretory immunoglobulin as (2005) (1)
IMMUNODEFICIENCY IN DOWN'S SYNDROME. AHTIBODIES TO E.COLI AND RABBIT ERYTHROCYTES AT DIFFERENT AGES (1978) (1)
Nickel-Specific Human T Cell Clones: Functional Characterization and Requirements for Triggering (1985) (1)
Rationally designed oral vaccines can set an evolutionary trap for Salmonella Typhimurium (2019) (1)
The Functional Relationship between Preferential Use of Newly Synthesized Class II Molecules and Their Stable Association with Peptides (1992) (0)
On the role of regulatory T cells and microbial products in the control of T and B cell immune responses (2006) (0)
36 INTERACTION OF LPS AND CONA IN HUMN LYMPHOCYTE ACTIVATION. II: EFFECT ON CELL PROLIFERATION (1979) (0)
T cells in patients with narcolepsy target self-antigens of hypocretin neurons (2018) (0)
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation (2021) (0)
CD40L+CD4+effector memory T-cells migrating into lymph nodes license dendritic cells for induction of autoimmunity (2008) (0)
26 ONTOGENETIC ASPECTS OF SECRETORY IMMUNITY (1979) (0)
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 2) (2019) (0)
Protection of calves by a prefusion-stabilized bovine RSV F vaccine (2017) (0)
Persistent antibody clonotypes dominate the serum response to influenza following repeated vaccination over multiple years (2018) (0)
An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells (2018) (0)
37 ConA-INDUCED THYMUS-DEPENDENT Ig PRODUCTION BY HUMAN B LYMPHOCYTES IN VITRO (1979) (0)
MGG4 Fab in complex with peptide (2018) (0)
MERS-CoV S complex with human neutralizing LCA60 antibody Fab fragment (state 2) (2019) (0)
SARS-CoV complex with human neutralizing S230 antibody Fab fragment (state 1) (2019) (0)
On the role of IL-1β and CNS myeloid cells in EAE pathogenesis (101.34) (2011) (0)
Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates (2023) (0)
1 Particle Conformation Regulates Antibody Access to a Conserved GII . 4 Norovirus 1 Blockade Epitope . 2 3 (2014) (0)
Erratum to Correction: Dengue Research Funded by the European Commission-Scientific Strategies of Three European Dengue Research Consortia (The PLOS Neglected Tropical Diseases Staff) (2014) (0)
Extremely potent Human Monoclonal Antibodies for the Prophylaxis and Therapy of Tetanus (2021) (0)
Dendritic cell traffic control by chemokines (2006) (0)
ANTIBODES TO HUMAN CD152 WITH PROPERTIES OF AGONIST, ANTAGONIST, (2017) (0)
Regulation of T lymphocyte priming and polarization by dendritic cells (2000) (0)
35 INTERACTION OF LPS AND ConA IN HUMAN LYMPILOCYTE ACTIVATION. I: SYNTERGISTIC EFFECT ON IgM PRODUCTION (1979) (0)
CD4 and CD8 can be recruited to triggered T cell receptors in the absence of interaction with the cognate MHC molecules (1997) (0)
Antibodies Against Neutralization Epitopes of Human Cytomegalovirus gH/gL/pUL128-130-131 Complex and Virus Spreading May Correlate with Virus Control In Vivo (2012) (0)
More on cancer vaccine (2005) (0)
How many ways can a killer cell kill? (1989) (0)
MERS-CoV complex with human neutralizing LCA60 antibody Fab fragment (state 1) (2019) (0)
How do viruses influence DC's antigen presenting capacity? (2000) (0)
The Role of Dendritic Cells in T‐cell Activation and Differentiation (2008) (0)
Activation of Human B Lymphocytes by Antigen Specific T Cell Lines (1983) (0)
L'allergia al latte vaccino come prototipo di allergia alimentaire (1977) (0)
Mechanisms of antigen-induced TCR downregulation (1997) (0)
T cell targeting with bispecific antibodies (1991) (0)
On the role of IL-1{beta} and CNS myeloid cells in EAE pathogenesis (2011) (0)
Machine learning predicts immunoglobulin light chain toxicity through somatic mutations (2019) (0)
Cell Fate Challenges in Specifying Effector and Memory T Division of Labor with a Workforce of One : (2008) (0)
Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C (2012) (0)
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae (2017) (0)
neutralizing antibodies against influenza virus A and uses of these (2009) (0)
, the Adaptive Immune System Epigenetic Flexibility Underlying Lineage Choices (2008) (0)
Structural basis of LAIR1 targeting by polymorphic Plasmodium RIFINs (2021) (0)
110 Broadly neutralizing antibodies for serotherapy and vaccine design (2014) (0)
Dissection of the reciprocal interaction between T helper cells and B cells during an immune response in vivo (90.4) (2009) (0)
Neutralizing antibodies of human cytomegalovirus and use thereof (2009) (0)
Correction to: Single‑cell profiling of myasthenia gravis identifies a pathogenic T cell signature (2021) (0)
SAT0030 CITRULLINE-REACTIVE B CELLS ARE PRESENT IN INFLAMED GINGIVAL TISSUE AND DISPLAY CROSS-REACTIVITY BETWEEN BACTERIAL AND HUMAN ANTIGENS (2019) (0)
Publisher Correction: An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells (2018) (0)
Longitudinal landscapes of serum antibody repertoires after influenza infection and vaccination (2016) (0)
Clonal composition and persistence of antigen‐specific circulating T follicular helper cells (2022) (0)
Dissecting the human T and B cell response to pathogens (LL2-3) Chairperson: Kayo Inaba (2010) (0)
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape (2022) (0)
Table of Contents (1991) (0)
HUMAN B CEIL DIFFERENTIATION IN VITRO. KINETICS TO THE RESPONSE TO POKEWEED MITOGEN (PWM) (1978) (0)
Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) (2020) (0)
Crystal Structure of a Complex formed between FLD194 Fab and Transmissible Mutant H5 Haemagglutinin (2015) (0)
STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ. (2011) (0)
Crystal structure of anti- MERS-CoV human neutralizing LCA60 antibody Fab fragment (2019) (0)
Homeostatic Proliferation of Chronic Lymphocytic Leukemia. (2005) (0)
Crystal structure of anti- SARS-CoV human neutralizing S230 antibody Fab fragment (2019) (0)
Human monoclonal antibodies and analytic vaccinology (2008) (0)
Different classes of genomic inserts contribute to human antibody diversity (2022) (0)
Distinct expression pattern of IFN- (cid:1) and TNF- (cid:1) in juvenile idiopathic arthritis synovial tissue (2007) (0)
Enforced STAT3 and PU.1 Expression Activates Type I Interferon-Producing Cell and Dendritic Cell Differentiation Programs in Megakaryocyte/Erythrocyte Progenitors. (2005) (0)
Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C (2012) (0)
Human cytomegalovirus-neutralizing antibodies and the use thereof (2008) (0)
Blocking tetanus with purified human monoclonal antibodies (2021) (0)
Myasthenia gravis: From single cell signatures to cancer diagnosis (2020) (0)
Dissecting the human T and B cell response to pathogens (2011) (0)
P04-52 LB. The importance of well-defined HIV-1 neutralization assays (2009) (0)
Monoclonal antibody-mediated clearance of rabies virus from the central nervous system: Implications for future approaches to rabies therapy (2016) (0)
Editorial overview Hildegund CJ Ertl and Antonio Lanzavecchia (2010) (0)
crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix (2010) (0)
The mannose receptor functions as a high capacity and broad specificity antigen receptor in dendritic cells (1997) (0)
Preparation of monoclonal antibodies by EBV transformation of B cells (2004) (0)
Flt3 Receptor Expression Rescues Dendritic Cell Developmental Potential in Megakaryocyte/Erythrocyte Progenitor Cells. (2004) (0)
Presentation of self-peptides: consequences for self nonself discrimination and allorecognition. (1993) (0)
Antigen-Binding Fragments From Purified Human Monoclonal Antibodies Open to the Intrathecal Therapy of Tetanus (2022) (0)

This paper list is powered by the following services:

Other Resources About Antonio Lanzavecchia

en.wikipedia.org

What Schools Are Affiliated With Antonio Lanzavecchia?

Antonio Lanzavecchia is affiliated with the following schools: